1. BD ranks in top 25% of Fortune's Most Innovative Companies for 2025. 2. The ranking highlights BD's commitment to developing innovative health solutions. 3. CEO Tom Polen emphasizes the importance of continuous improvement at BD. 4. BD's global reach touches billions of patients through innovative medical devices. 5. Recognition may enhance investor confidence in BD's growth strategy.
Being recognized as an innovative company can lead to increased investor confidence and potential sales growth, similar to past instances where innovation led to stock price upticks for medical tech companies. For example, when Medtronic was recognized for innovation, its stock saw a boost of over 10% in subsequent months.
The recognition in Fortune raises BD's profile among investors and stakeholders, likely enhancing interest and support for its ongoing and future innovations, signifying the company's positioning as a leader in the medical technology field.
The long-term impact stems from the brand strengthening and sustained innovation initiatives, which can lead to market share expansion and revenue growth over the years, akin to how companies like Intuitive Surgical sustained growth following similar accolades.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.
"As one of the largest manufacturers of medical devices in the world whose products touch billions of patients around the globe, building on our long history of innovation is a responsibility we take very seriously," said Tom Polen, chairman, CEO and president of BD. "Through the ingenuity of our world-class team who strives to address unmet needs in healthcare every day, coupled with BD Excellence - our culture of continuous improvement - we can live our purpose and manufacture innovative medical products at scale as we deliver for our customers and the patients we serve."
Fortune and Statista surveyed more than 40,000 U.S. employees and more than 2,500 industry experts to rank companies across the following three categories:
For a full list of awards and recognitions BD has received, visit news.bd.com/Award-news.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Jessica Offerjost
BD Public Relations
201-258-0964
jessica.offerjost@bd.com
Adam Reiffe
Sr. Director, Investor Relations
201-847-6927
adam.reiffe@bd.com
SOURCE BD (Becton, Dickinson and Company)